Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 20, 2003

View Archived Issues

Aerogen initiates phase II pulmonary amikacin study

AEterna updates pipeline status following Zentaris acquisition

Miravant presents novel porphyrins for the diagnosis and treatment of vascular disorders

BMS scientists prepare new MMP, TACE and/or aggrecanase inhibitors

Pyrimidine-based CDK inhibitors and their use claimed by AstraZeneca

Novel activators of KCNQ channels and their use in migraine, neuropathic pain, etc.

GSK researchers describe novel series of PPARalpha agonists

ARYx reports new anticholinergics with utility in urinary incontinence and COPD

CytRx grants option to PSMA for TranzFect adjuvant

Chiron to transfer SILCAAT study to trial investigators

DSMB recommends that phase III Thymitaq trial continue

InSite Vision finalizes ISV-401 phase III trial protocol

Novartis obtains rights to pirenzepine for myopia from Valley Forge

Vion executes clinical trials agreement for Triapine with NCI

FDA committee backs Aldurazyme efficacy

Another AlgoRx product advances to clinical trials

Molecular mechanisms underlying alpha7 nAChR-mediated neuroprotection

Structurally novel class of inhibitors of VEGFR kinase discovered by Schering AG/Novartis

Possible explanation for sildenafil-associated thrombotic conditions

Long-term effects of tranilast in oligoasthenozoospermia

Comparative neuroprotective properties of CHF-3381, lamotrigine and MK-801

Tacrolimus reported safe and effective in chronic actinic dermatitis

Good safety profile reported for zosuquidar plus doxorubicin in advanced tumors

Clinical benefits induced by celecoxib in coronary artery disease

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...